v3.26.1
INTANGIBLE ASSETS (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Oct. 12, 2018
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Accumulated amortization   $ (44,581)   $ (44,581)   $ (36,440)
Customer [Member]            
Amortization expense   8,382 $ 67,552 16,672 $ 88,337  
Intangible assets acquired fair value   336,200   336,200    
Accumulated amortization   44,581   $ 44,581    
Estimated useful lives       10 years    
Intellectual Property [Member]            
Amortization expense   0 $ 295 $ 295 $ 589  
Impairment of intellectual property   0   6,374    
Naltrexone Implant Formulation [Member] | Australia from Trinity Compound Solutions [Member]            
Patent acquired purchase price $ 15,200          
Estimated useful lives 13 years          
Trademarks [Member]            
Intangible assets acquired fair value   $ 249,500   $ 249,500